Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213 Bi-DTPA-[F3] 2 into the Nucleus of Tumor Cells
Enken Drecoll, Florian C. Gaertner, Matthias Miederer et al. · 2009
Read Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213 Bi-DTPA-[F3] 2 into the Nucleus of Tumor Cells by Enken Drecoll, Florian C. Gaertner, Matthias Miederer et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005715.txt.
Description
Enken Drecoll and colleagues tested in 2009 a way to deliver radiation straight into tumor cells in the belly cavity. Cancers that spread across the peritoneum, the lining of the abdomen, are hard to treat. Alpha-particle radiation kills cells well but must not stray into healthy tissue.
The team attached a radioactive tag to a peptide that homes to tumors. The carrier aims to place the dose inside the tumor cell's nucleus, its control center. A hit there does the most damage to the cancer cell. The study checks whether this aimed delivery works as hoped in practice.
Catalog record
| CREATOR | Enken Drecoll, Florian C. Gaertner, Matthias Miederer et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005715